Therefore, we recommend a new molecular approach which illustrates that HSF1 and its target HIF‐1α/VEGF signalling pathway influences the exercise training‐activated cardioprotection against pressure overload–initiated cardiac hypertrophy (Figure 5). The gene discussed is HIF1A; the disease is cardiac hypertrophy.